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Introduction
In the US the AP has a prevalence of 3.3%, for 
men – 3.4%, and for women – 3.2%. In the European 
countries, according to the data of European Society 
of Cardiology (ESC), the prevalence of AP raises in-
creases with age for both sexes: from 4-7% for men 
aged between 45 and 64, and from 5-7% from the 
women of the same age, from 12-14% for the men 
aged between 65 and 84 and 10-12% for women of 
the same age [1, 2]. 
The most common AP complication is the acute 
myocardial infarction (AMI). In the United States 
the prevalence of the myocardial infarction among 
adults aged ≥20 is 2.8%, 4.0% for men and 1.8 for 
women. The scientists, who studied this field, have 
calculated that every 43 seconds an American citi-
zen may develop AMI [1]. According to population 
studies of Olmsted County and Framingham, the 
patients with AP develop AMI in 3.-3.5 % per year, 
so in 30 patients with AP, the AMI progresses in one 
person [2, 5].
In the United States, IHD causes 146.5 deaths 
per 100000 of population among men and 80.1 per 
100000 of population among women. IHD is res-
ponsible for 25.3% of deaths [4, 5]. In Europe, IHD is 
responsible for 1.8 million of deaths per year, which 
corresponds to 20% of men and 21% of women. In 
the Republic of Moldova the death rate because of 
IHD per 100.000 of population is 138 per men and 
51 per women, simultaneously, Romania presents 
a death rate approximately 2 times smaller: 75 per 
100.000 of population – men and 21 per 100.000 – 
women, and the highest death rate because of IHD 
is in Russia: 186 per 100.000 of population – men and 
44 per 100.000 of population – at women [6]. 
Various observational studies have proved the 
existence of sex differences both in clinical and pa-
raclinical presentation, and in therapeutic options 
which are not effective and safe in equal measures 
for men and women. At the same time, it has been 
proved that the men are involved to a lesser extent 
in the population studies pointing the cardiovas-
cular diseases, so from 62 randomized studies in 
Europe only 33.5% of participants were women [3, 
5]. It was found that men with AP who seek medical 
attention have a superficial approach, involving 
more frequently the noninvasive methods versus the 
invasive methods, and they have a lesser possibility 
than men of revascularization treatment. So, among 
the men with AP, 4.2% of them dispose of revascula-
rization, meanwhile only in 2.4% of women with AP 
dispose of this option of treatment [2, 5].
Taking into consideration the growing of the 
incidence of AP in women, the determination of 
a late diagnosis because of clinical atypical mani-
festations and the reduced involvement of women 
with AP in population studies, we intend to study 
the AP peculiarities of women from the Republic of 
Moldova, which means an actual health and social 
problem.
The aim of the study: to study the etiological, 
clinical and paraclinical peculiarities and the treat-
ment of stable angina in men. 
Objectives of the study. To study the cardiac 
predisposing factors and comorbidities in men with 
stable angina. To analyze the peculiarities of clinical 
evolution of stable angina in men. To evaluate the 
paraclinical results in patients that was included in 
the study. To evaluate the treatment of stable angina 
in men.
The study included 116 patients with AP, ad-
mitted to the Municipal Hospital Sfanta Treime and 
the Cardiological Institute during September 2015 
– November 2016. Diagnostic of Stable Angina was
determined by clinical criteria: anamnesis, clinical 
manifestations, objective data; instrumental exa-
mination: electrocardiography in all patients, effort 
test and coronary angiography in patients selected 
for revascularization by coronary artery bypass graf-
ting, Holter monitor ECG, stress test medication in a 
group of patients for technical reasons; Laboratory 
tests: lipidogram, coagulation, blood glucose, blood 
counts in all patients, and markers of myocyte injury 
in some patients with UAP for financial reasons. 
Results and discussions
According to the study goals and objectives, 
we analyzed in detail AP patients with predisposing 
factors to determine, comorbidities, clinical ma-
nifestations and complications, results paraclince 
specific treatment and preventive measures in these 
patients. Starting from the paper’s purpose patients 
were divided into 2 groups according to sex. In our 
study group were predominantly men, numbering 
67, which constituted 57,8%, compared to women 
– 49 which corresponds to 42,2%. AP increased pre-
valence among men is explained by the fact that 
women have a protective role of ovarian hormones 
in premenopausal period. We aimed to evaluate 
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patients in the study depending on age and sex, the 
data is illustrated in the following graphic.
In patients aged up to 64 years, AP predomi-
nates in men than women: ≤44 years (2,8% vs 0%), 
45-54 years (16,5% vs 9,2%); 55-64 years old (46,5% 
vs 29,4%) and after age 65, AP prevalence is higher 
in women compared to men: 65-74 years old (32% 
vs 22,8%); 75-84 years old (26,8% vs 11%); ≥85 years 
(2,6% vs 0,4%). This phenomenon can be explained 
by the combination of a new risk factor in women 
and certain post-menopausal and longer life expec-
tancy of women than men [1, 4].
Analyzing the results, we note that the initial 
diagnosis of AP was established more frequently in 
men (62.6%) compared to women (51.6%). Acute 
Coronary Syndrome was suspected equally to men 
(22.4%) and women (23.72%). At the same time, wo-
men were hospitalized more frequently with other 
diagnoses (24.2%) vs men (12.2%). 
According to the pain location, we can observe 
that in men typical retrosternal pain and precordial 
pain is determined 82,4% vs 88,5% in biggest pro-
portion compared to women‘s. At the same time, for 
women’s prevailed pain in the atypical locations in 
5.2% and missing of the pain in 12.4%. This results 
is explaining by a big prevalence of atypical clinical 
picture of AP.
Analyzing this obtained results, we can obser-
ve, that men’s pain radiates predominantly on a left 
shoulder – 67.2 % vs 48.4 %, during the time that 
extension of the pain in other regions is present 
more frequently for women’s. In the left shoulder and 
hand – 17.8% vs 9.8%, interscapulo – vertebral 17.8% 
vs 14.8%, throat – 8% vs 6.6%, mandible – 3.2% and 
other locations – 4.8% vs 1.6%. Studying the data 
obtained, we note that in most of the patients, the 
AP gives the administration of nitroglycerin, a rate 
less prevalent in men (59.1%) than in women (62.3%). 
Anginal pain at rest was determined that yield more 
often in men (21.5%) than in women (17.1%), and 
improving crisis management nitroglycerin angina 
both at rest and was in an amount almost equal to 
both sexes 19.4% vs 20.6%. Various observational 
studies have proved the existence of sex differences 
both in clinical and paraclinical presentation, and in 
therapeutic options which are not effective and safe 
in equal measures for men and women. At the same 
time, it has been proved that the men are involved 
to a lesser extent in the population studies pointing 
the cardiovascular diseases, so from 62 randomized 
studies in Europe only 33.5% of participants were 
women [Stramba-Badiale M., 2009]. It was found 
that men with AP who seek medical attention have 
a superficial approach, involving more frequently 
the noninvasive methods versus the invasive me-
thods, and they have a lesser possibility than men 
of revascularization treatment. So, among the men 
with AP, 4.2% of them dispose of revascularization, 
meanwhile only in 2.4% of women with AP dispose 
of this option of treatment. In the study group gr 
II IC prevailed in almost equal proportion in both 
sexes, women (57.8%) vs men (59.1%), followed by 
IC gr. III (36.2%) vs. (35.6%). Gr. IV IC and IC gr. I was 
in the minority.
We should notice that the anti-ischemic thera-
py, most commonly administered beta-AB, slightly 
more prevalent in men (73.2%) vs (68.6%), BCC, com-
monly administered to women (56.2%) vs ( 44.5%) 
and less nitrates: 14.9% for women vs 12.2% men. 
The cytoprotective benefited equally to men (41.3%) 
and women (39.2%). For prophylactic antiplatelet 
prevailed slightly more prevalent in men (71.2%) 
vs women (70.3%). Statins and anticoagulants were 
given less frequently in women.
Conclusions
Angina pectoris is higher in men than in women 
(57,8% vs 42,2%). The rate of pathology is changing 
with age, up to 64 years, angina is more frequent is 
meat in men (65,8%) vs 38,6 in women, and after the 
age of 65 years, women prevail (61,4% vs 34,2%). 
In patients with angina clinical picture was more 
often represented by the retrosternal pain in 52,7% 
and dependent in physical exertion in 68,5% of 
medium intensity, with a duration of 5-10 minutes 
at those with stable angina (15,9%) and 20 minutes 
from those with unstable angina (14,7%), that were 
ameliorated after nitroglycerin intaking. Men rep-
resenting the angina pectoris have administrated 
the pharmacological treatment mostly with: notice 
that the anti-ischemic therapy, most commonly ad-
ministered beta-AB, slightly more prevalent in men 
(73.2%) vs (68.6%), BCC, commonly administered to 
women (56.2%) vs (44.5%) and less nitrates: 14.9% 
for women vs 12.2% men.
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